Retrospective Study
Copyright ©The Author(s) 2019.
World J Hepatol. Dec 27, 2019; 11(12): 752-760
Published online Dec 27, 2019. doi: 10.4254/wjh.v11.i12.752
Table 4 Management and outcomes, n (%)
GCH on native liver, n = 40GCH on allograft, n = 10
Management
Immunosuppression11 (28)4 (40)
Supportive care10 (25)0 (0)
Liver transplantation5 (13)1 (10)
Ganciclovir1 (3)1 (10)
Unknown13 (33)4 (40)
Outcomes
Survived25 (63)4 (40)
Died5 (13)2 (20)
Unknown10 (25)4 (40)